alexa Pharmaceutical Cancer Nanotechnology: Shortening Hurtles to Clinical Translation | Abstract

Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication Open Access


Nanoparticles offer a distinct array of properties that may potentially improve cancer therapy. Nanoparticles possess an extraordinarily large surface-area-to-volume ratio for drug loading, increased blood circulation half-life, and inherent contrast enhancing properties for imaging purposes. Therefore, nanoparticle research has been exponentially accelerated for the past 15 years, and translational research greatly aided by the NCI Alliance for Nanotechnology in Cancer and Nanotechnology Characterization lab.

To read the full article Peer-reviewed Article PDF image

Author(s): Forrest M. Kievit, Richard G. Ellenbogen and Miqin Zhang


Nanoparticles, polymeric targeted delivery, Genetic mutation, Pharmaceutics,Alternative Medicines,Biopharmaceutics

Recommended Journals

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version